CRIS Connect - Navigating Cell, Tissue and Gene Therapy Product (CTGTP) Development in ACTRIS
Topics
Webinars
10 September 2026
Gain practical insights into the scientific, regulatory, and operational considerations involved in advancing cell, tissue and gene therapy products from bench to bedside through expert-led discussions and real-world perspectives.
Registration is now closed.

💉Advanced therapies are reshaping what is possible for patients with life-threatening and rare diseases. But how do these novel treatments move beyond the research stage and into clinical practice?
The development of cell, tissue and gene therapy products (CTGTPs) presents unique scientific, manufacturing and regulatory processes. Successfully navigating these complexities requires coordinated expertise, infrastructure and governance across the entire development pathway.
✨ In our June webinar, hear from Dr Lee Lee Ong (opens in new tab) on Singapore's regulatory landscape for CTGTPs, as well as Mr Vincent Jong, PMP® (opens in new tab) on the practical considerations involved in advancing these therapies from bench to bedside. We are pleased to have with us, Dr Lip Kun Tan (opens in new tab) as the moderator for this session.
Date: Thu, 25 Jun 2026
Time: 2pm - 3pm
Mode: Online via Zoom
Register here today: https://for.sg/crisconnect (opens in new tab)
🔬 These domain experts from Singapore's CTGTP ecosystem will examine the frameworks and processes that enable the safe and compliant development of advanced therapies, drawing on local experiences including that of CAR-T therapies supported by ACTRIS.
CRIS Connect is a monthly webinar series organised by Singapore Clinical Research Institute (SCRI) (opens in new tab) and supported by our programmes and their ecosystem partners.
Find out how our collective effort is advancing national-level R&D initiatives such as: the clinical trials ecosystem, healthcare innovation and clinical adoption, precision medicine, cancer and cardiovascular research programmes, as well as cell therapy manufacturing.

